Two new FDA initiatives would promote generic competition through updated labeling and more efficient reviews, according to Commissioner Scott Gottlieb.
Source: Drug Industry Daily
Two new FDA initiatives would promote generic competition through updated labeling and more efficient reviews, according to Commissioner Scott Gottlieb.
Source: Drug Industry Daily